| Price | $2.41 |
| Year Range | $2.29 – $10.96 |
| Market Cap | $19M |
| Industry | Medical Devices |
What Is PAVmed’s AI Stock Analysis?
PAVmed’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks PAVmed’s momentum in near-real time.
PAVmed (PAVM) has an AltIndex AI Score of 35/100, currently a Sell signal. The AI Score distills PAVmed's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
PAVmed’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of PAVmed — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving PAVM’s AI Score?
Fundamentals
Revenue for the last quarter was $33,000. This is an increase of 50.00% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 450.00%, suggesting positive year-over-year growth. Net income for the last quarter was $-5.4M. This represents a decrease of 8,873.33% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -54.84%, suggesting positive year-over-year growth. Ebitda for the last quarter was $-7.4M. This represents a decrease of 614.51% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -39.52%, suggesting positive year-over-year growth.
See PAVmed’s earnings and insider transactions.
Technicals
Today's stock price is $2.41. This represents a decrease of 39.29% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 84.16%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $2.63, which is lower than the previous SMA10 of $2.65. This suggests a potential downward trend in price movement. The RSI is 28.3, indicating a potentially oversold (bullish) condition.
See the full technical analysis and price prediction.
Alternative data
PAVmed has an estimated 0 open positions. This number is down by -100% in the last couple of months, indicating a company trying to improve its margins or cut costs. Not a great sign for a growing company. The business outlook among employees at PAVmed is neutral. PAVmed has an estimate of 2,000 visitors to their webpage, with no meaningful increase or decrese in the last couple of months.
Explore PAVmed’s job postings, web traffic and app downloads.
Sentiment & social
Add to that that the sentiment is down by -100% in the last couple of weeks, an even more concerning trend. PAVmed has 1,300 followers on their Twitter page. The number of followers is down by -1% in the last couple of months, indicating a loss in interest in the company.
Track PAVmed’s market sentiment.
Frequently Asked Questions: PAVmed AI Stock Analysis
PAVmed's AltIndex AI Score is 35/100, currently a Sell signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates PAVmed a Sell (35/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of PAVmed — company overview, fundamentals, technicals and alternative data, with a recommendation. See the PAVM AI Score or sign up to read the full thesis.
